1. Home
  2. HRMY vs METC Comparison

HRMY vs METC Comparison

Compare HRMY & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$28.56

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Ramaco Resources Inc.

METC

Ramaco Resources Inc.

HOLD

Current Price

$15.26

Market Cap

1.8B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
METC
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Coal Mining
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HRMY
METC
Price
$28.56
$15.26
Analyst Decision
Buy
Buy
Analyst Count
10
8
Target Price
$46.70
$33.94
AVG Volume (30 Days)
1.1M
2.1M
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
7.97
N/A
EPS
2.71
N/A
Revenue
$868,453,000.00
N/A
Revenue This Year
$18.83
$22.05
Revenue Next Year
$12.69
$13.17
P/E Ratio
$10.70
N/A
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$6.30
52 Week High
$40.87
$57.80

Technical Indicators

Market Signals
Indicator
HRMY
METC
Relative Strength Index (RSI) 31.12 40.15
Support Level $26.36 $14.67
Resistance Level $37.98 $19.13
Average True Range (ATR) 1.89 1.33
MACD -0.55 -0.12
Stochastic Oscillator 21.93 31.68

Price Performance

Historical Comparison
HRMY
METC

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: